Irritable bowel syndrome (PDS, internationally called IBS) is often viewed as a functional disorder with no apparent cause. Yet more and more research points to a complex interplay between genetic predisposition, microbiome and environmental factors. At My InnerSelfie, we put those layers together: DNA, metabolites and microbiome - and clarify why some people develop symptoms and others do not.

PDS ≠ Crohn's or colitis (IBD)

It is important to make the distinction sharply:

• PDS/IBS (irritable bowel syndrome): functional disorder without obvious inflammation. Symptoms include cramps, bloating, diarrhea or constipation.
• Crohn's disease & ulcerative colitis (IBD): chronic inflammatory bowel disease, often with marked inflammatory markers and structural abnormalities.

Yet some genetic and microbial mechanisms overlap. Thus, we see that in both PDS and Crohn's, the dialogue(crosstalk) between host and microbiome becomes disrupted.

Secretor status (FUT2) and IBS

One of the best known genetic factors is the FUT2 variant.

• Secretors (80%): secrete blood group antigens into the intestinal mucosa, which serve as "food" for certain bacteria.
• Non-secretors (20%): lack this, so the gut flora contains less Bifidobacterium and is more prone to dysbiosis.

Studies show that non-secretors are more likely to suffer from PDS and sometimes at higher risk for IBD. (Rausch et al., PNAS, 2011)

Genetic links to inflammatory bowel disease (IBD)

Although PDS is not an inflammatory disease, insights from IBD teach much about host-microbiota interactions:

• ATG16L1 variant: affects autophagy in Paneth cells, crucial for regulating bacteria in the small intestine. Defects lead to increased susceptibility to Crohn's disease.(Caruso et al., Nature Reviews Immunology, 2020)
• Gene-environment interaction: genetic predisposition alone is not sufficient; environmental factors such as diet, infections and medications (e.g., regular use of NSAIDs/aspirin) can lower the threshold to disease in a susceptible host. (Sartor, Gastroenterology, 2010)
• Microbiome imbalance: in Crohn's and colitis, we see a strong shift in bacterial composition, which may give similar - but milder - patterns in PDS. (Wlodarska et al., Cell Host & Microbe, 2015)

Why this matters in PDS

Even though PDS is not Crohn's, the same themes come into play:

• Genetic vulnerability (FUT2-secretor status, variants in autophagy genes).
• Microbial signature (lower proportion of beneficial bacteria, higher inflammation susceptibility).
• Environmental stimuli (diet, stress, medication use such as aspirin or antibiotics).

My InnerSelfie combines this in a multi-omics analysis: DNA + metabolites + microbiome, so you understand why your gut reacts the way it does.

Biohacking & preventive strategies

• DNA insight: discover if you are non-secretor or have an increased predisposition to imbalance.
• Microbiome test: analyze which bacteria are missing or dominating.
• Metabolites mapping: see if low-grade inflammation or disrupted fermentation plays a role.
• Dietary and lifestyle approach: in non-secretors, HMO-like prebiotics or postbiotics often work better than classical fiber increases.
• Conscious medication use: when predisposed, be careful with long-term aspirin/NSAIDs and always coordinate with your doctor.

Key insights

• PDS is a functional disorder, but genetics and microbiome play a role.
• FUT2-secretor status determines the composition of your gut flora and your sensitivity.
• Overlapping mechanisms such as ATG16L1 mutations and microbial imbalance are at play in IBD (Crohn's, colitis).
• Environmental factors, such as aspirin, can amplify genetic vulnerability.
• My InnerSelfie offers a multi-omics approach to understanding IBS not superficially, but deeply.

Scientific references

• Caruso R, Lo BC, Núñez G. Host-microbiota interactions in inflammatory bowel disease. Nature Reviews Immunology. 2020.
• Wlodarska M, Kostic AD, Xavier RJ. An integrative view of microbiome-host interactions in inflammatory bowel diseases. Cell Host & Microbe. 2015.
• Rausch P, Rehman A, Künzel S, Häsler R, et al. Colonic mucosa-associated microbiota is influenced by an interaction of Crohn disease and FUT2 genotype. PNAS. 2011.
• Zhou H, Beltrán JF, Brito IL. Host-microbiome protein-protein interactions capture disease-relevant pathways. Genome Biology. 2022.

Sartor RB. Genetics and environmental interactions shape the intestinal microbiome to promote inflammatory bowel disease versus mucosal homeostasis. Gastroenterology. 2010.